Blockchain in Clinical Trials
Update – May 2025 Since my original post six years ago, many of the ideas and proposed blockchain solutions in Pharma and Healthcare remain largely conceptual. There has been limited visible progress in terms of broad implementation. One notable development was the FDA’s pilot project under the Drug Supply Chain Security Act (DSCSA), which aimed to evaluate interoperability of systems for tracing prescription drugs. The final report was published and described the pilot as successful. However, there is still little publicly available information regarding the cost evaluation of blockchain-based solutions, or the specific technical architectures used (e.g., Web3 identifiers, DAOs, or private blockchain networks). 📄 References 1. FDA (2023). DSCSA Pilot Project Program: Final Report. https://www.fda.gov/media/168279/download 2. Chronicled / MediLedger (n.d.). Success Stories – Real-World Blockchain Applications in Pharma Supply Chain. https://www.chronicled.com/success-stori...